Marbocine® 100
Third Generation Fluoroquinolone, Broad Spectrum and Wide Tissue Distribution
Injectable Solution
Each 1 mL contains:
Marbofloxacin ………………………………… 100 mg
Excipients c.s.p ……………………………… 1 mL
Bovine: Treatment of respiratory infections caused by sensitive strains of Pasteurella multocida, Mannheimia haemolytica and Mycoplasma bovis. Treatment of acute mastitis caused by E. coli strains sensitive to marbofloxacin during the lactation period. Swine: Treatment of mastitis-metritis-agalactia syndrome caused by bacterial strains sensitive to marbofloxacin. Canines and felines: treatment of infections caused by bacterial strains sensitive to marbofloxacin.
Injectable intramuscular, subcutaneous or intravenous route.
Cattle: Pasteurella multocida, Mannheimia haemolytica: 2 ml / 25 kg pv. Mycoplasma bovis: 1 ml / 50 kg pv
Mastitis: 1 ml / 50 kg live weight.
Swine: 1 ml / 50 kg live weight
Canines and felines: 0.125 ml / 6.25 kg live weight
Bottle x 50 mL , Bottle x 100 mL , Bottle x 250 mL .
SENASA Registry: SENASA Perú: F.8201.I.0328
Print
Brochure
Insert
ShareThis content is informative reference and should not be considered as prescriptions.
